The Effect of Caffeine on the Narcoleptic Patients
The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial
Sponsor: King Saud Medical City
This PHASE1/PHASE2 trial investigates Narcolepsy and is currently completed. King Saud Medical City leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Apr 2019 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Recruiting → Completed
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- King Saud Medical City
- King Saud University
For direct contact, visit the study record on ClinicalTrials.gov .